Although the use of the PSFS as an outcome measure is increasing in physiotherapy practice, there are gaps in the research literature regarding its validity, reliability, and responsiveness in many health conditions.
T here has been a shift in current health practices toward patientfocused outcome measures in rehabilitation. 43 In response to this shift, the need for individualized outcome measures has become more apparent. 20 , 43 Stratford et al 69 describe this in more detail as being a change from impairment-based to functionbased measurement. This view is supported by Pengel et al, 58 who found that disability and function measures were more responsive than impairment measures in a population with subacute low back pain. A move away from practitioner-based measures to a more holistic approach, centering T T STUDY DESIGN: Systematic review of the literature.
T T OBJECTIVE:
To summarize peer-reviewed literature on the reliability, validity, and responsiveness of the Patient-Specific Functional Scale (PSFS), and to identify its use as an outcome measure.
T T METHODS:
Searches were performed of several electronic databases from 1995 to May 2010. Studies included were published articles containing (1) primary research investigating the psychometric and clinimetrics of the PSFS or (2) the implementation of the PSFS as an outcome measure. We assessed the methodological quality of studies included in the first category.
T T RESULTS:
Two hundred forty-two articles published from 1994 to May 2010 were identified. Of these, 66 met the inclusion criteria for this review, with 13 reporting the measurement properties of the PSFS, 55 implementing the PSFS as an outcome measure, and 2 doing both of the above. The PSFS was reported to be valid, reliable, and responsive in populations with knee dysfunction, cervical radiculopathy, acute low back pain, mechanical low back pain, and neck dysfunction. The PSFS was found to be reliable and responsive in populations with chronic low back pain. The PSFS was also reported to be valid, reliable, or responsive in individuals with a limited number of acute, subacute, and chronic conditions. This review found that the PSFS is also being used as an outcome measure in many other conditions, despite a lack of published evidence supporting its validity in these conditions. The Patient-Specific Functional Scale: Psychometrics, Clinimetrics, and Application as a Clinical Outcome Measure on the patient and the patient's quality of life, has been described by several authors. 20, 48 Another driver of change in the use of outcome measures is the growing competition in healthcare and the need for practitioners to prove the efficacy of their treatments to patients and various funding agencies. 4 As clinical practice is time intensive, clinicians have become sensitive to changes in practice that consume valuable time. 15 These changes have prompted an increase in the research and development of more user-friendly, patient-specific outcome measures. 43 The Patient-Specific Functional Scale (PSFS) is a self-reported, patient-specific measure, designed to assess functional change, primarily in patients presenting with musculoskeletal disorders. The scale was developed by Stratford and colleagues 70 as a self-report measure of function that could be used in patients with varying levels of independence. Their original description states, "Patients are asked to identify up to five important activities they are unable to perform or are having difficulty with as a result of their problem. In addition to identifying the activities, patients are asked to rate, on an 11-point scale, the current level of difficulty associated with each activity." 70 Following intervention, patients are again asked to rate the activities previously identified and are given the chance to nominate new problematic activities that might have arisen during that time. 70 For the complete version of the PSFS, refer to APPENDIX A. Chatman et al 7 provide some examples of patient-nominated items. The proposed advantages of the PSFS include its wide applicability and ease of use clinically, 81 both desirable attributes in an outcome measure. Currently, the PSFS is used by clinicians, researchers, and healthcare policymakers in their respective settings. 7, 35 It has been proposed that the PSFS be incorporated into the verbal exchange that occurs between therapist and patient, to highlight the functional problems as reported by patients and to document the interaction for clinical interpretation. 15, 36, 70 Though the PSFS has become more commonly used in clinical research reports, the evidence supporting its clinimetric and psychometric properties remains incomplete. The aims of this systematic review are (1) to summarize evidence regarding the reliability, validity, and responsiveness of the PSFS, and (2) to identify its various uses in the peer-reviewed literature as an outcome measure. By collating this information, the authors aim to highlight areas that require further research.
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METHODS
A
comprehensive search of electronic databases was conducted in May 2010 to locate peer-reviewed articles, the results of which were narrowed to include human studies published from 1994 to May 2010. The start of this time frame was chosen to include the first article on the PSFS, which was published in 1995. 70 Studies were identified through searches of Academic OneFile, AMED, CINAHL, Current Contents Connect, EMBASE, Medline, PEDro, PubMed, Scopus, and Sport Discus electronic databases. Search terms used were "Patient-Specific Functional Scale" or "Patient Specific Functional Scale." Further studies were identified by manually searching the reference lists of all reviews or clinimetric articles retrieved and, where indicated, contacting the authors of articles to identify additional sources of information.
The included studies were required to be peer-reviewed, published articles (1) of primary research investigating the clinimetrics of the PSFS or (2) using the PSFS as an outcome measure. Excluded studies were (1) previously written reviews regarding the PSFS and (2) those that mentioned, but neither utilized nor investigated, the PSFS. In the first phase of the assessment, the abstracts of articles identified in the search were reviewed to assess the articles' eligibility for inclusion in the review. Abstracts that did not clearly state that the PSFS had been used as an outcome measure or for assessment of function in the study were excluded from review. A list of studies identified by the search were divided equally among 4 investigators (K.K.H., S.J., G.R., and D.v.V.), who individually applied the inclusion/ exclusion criteria to each article, which a second investigator then confirmed.
The studies were then categorized as being relevant to the first or second aim of the review. The first aim of the studyto summarize evidence regarding the reliability, validity, and responsiveness of the PSFS-was addressed in part 1. The second aim-to identify the various uses of the PSFS as an outcome measure in the peer-reviewed literature-was addressed in part 2. Data were extracted into tables specific to part 1 or 2 of the review. Data from each part were extracted individually by 1 of the 4 investigators and, subsequently, confirmed by a second investigator. Any disagreement regarding application of inclusion/exclusion criteria, categorization, or data extraction was settled by consensus between 2 investigators following additional review of the article and discussion.
The studies included in part 1 were assessed for their methodological quality using a checklist designed by Terwee et al, 72 developed specifically for assessing the quality of research reports on the measurement properties of health status questionnaires, for the purpose of systematic review. Articles were appraised by 2 investigators independently, and differences in their assessments were resolved by consensus of a third investigator.
The many different interpretations of the psychometric and clinimetric elements reviewed by the authors are outlined in the following descriptions.
The reliability of an outcome measure indicates consistency in use, with high test-retest reliability indicating that, when repeated under the same conditions, the measure is likely to yield the same results. 4 One method to evaluate test-retest reliability is the intraclass cor- relation coefficient (ICC), which gives a score between 0 and 1 for the outcome measure being assessed. The closer the score is to 1, the more reliable the outcome measure. 63 A score of 0.9 or higher indicates that the reliability for that outcome measure is excellent, 0.8 to 0.89 indicates that the measure has good reliability, while a score of 0.79 and below indicates poor reliability. 4 Standard error of measurement (SEM), another statistic used in reliability assessment, is defined as the amount of possible error in the measure, expressed in the original units of measure. 4 The validity of an outcome measure indicates that the measurement instrument is evaluating what it proposes to evaluate. 61 For an outcome measure to be accepted and utilized within a clinical setting, it should be assessed for its proposed purpose and shown to be applicable in a specified population. 61 Validity can be broken into further types, as displayed in TABLE 1. Where correlation between variables was calculated using the Pearson correlation coefficient (r), we accepted r = 0.70 or greater as evidence that validity was demonstrated in the context of outcome measures evaluating the same construct. 72 Responsiveness was defined as the ability of an outcome measure to detect important change over time. 20 Responsiveness, or sensitivity to change, can be measured and defined in terms of internal and external responsiveness, and evaluated using a number of different approaches. For the purposes of this review, the following definitions have been used: • External responsiveness identifies change in a measure by comparing it to a reference outcome measure, 40 commonly patient perception, 42 to derive a minimum value denoting meaningful change. Accuracy of that value is most commonly measured using receiver operating characteristic (ROC) curve analysis. 69 -Minimal clinically important difference (MCID): the smallest change in score that indicates clinically meaningful change, with respect to patient perception.
42
-ROC area under the curve (AUC): a measure of the ability of a questionnaire to distinguish between those patients who have and have not changed according to an external criterion.
70
• Internal responsiveness indicates the ability of a measure to change over a prespecified period 40 and is most commonly calculated using effect size (ES) or standardized response mean (SRM). 69 -ES: a standardized value that compares scores from initial to final assessment.
58
-SRM: a form of ES that measures responsiveness by dividing the mean change score by the standard deviation of score change.
49
-Minimal detectable change (MDC): the amount of change necessary to indicate true change, over and above potential measurement error.
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For the purposes of part 2, we classified the PSFS as the primary outcome measure, when this was specifically stated in the article, it was the only measure of function or disability presented, or it was discussed as the main outcome of 2 or more measures of function or disability. The use of the PSFS was determined to be a secondary outcome measure, when this was stated or greater emphasis was focused on another outcome measure (either of function/disability or another outcome, such as pain). When the use of the PSFS in a study was unclear or fell into neither of the above classifications, it was described as "unclear."
RESULTS
Study Selection
T he electronic database search and secondary sources yielded 242 articles. These were screened for eligibility by applying the inclusion and exclusion criteria, with 176 excluded. We obtained full-text versions of the remaining 66 articles included in this review. This process is illustrated in the FIGURE.
Full summaries of the reviewed studies can be found in APPENDICES C and D (available online at www.jospt.org).
Quality Assessment
The methodological quality assessment of the psychometric and clinimetric studies included in part 1 of this review can be seen in TABLE 2. Overall, the measurement properties assessed were evident within each study, thus allowing assessment of methodological quality. The findings of this assessment did not affect the conclusions made on the psychometric and clinimetric properties of the PSFS in this review.
Reliability
The reliability of the PSFS was assessed in 9 of the studies reviewed. Each of these studies used test-retest calculations to determine the ICC, as displayed in the Pain Self-Efficacy Questionnaire, and the numeric rating scale, and found that all of them showed excellent reliability. The PSFS was found to have excellent reliability when used for patients with cervical dysfunction 81 and good reliability in those with cervical radiculopathy.
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In a population with cervical dysfunction, the PSFS was compared with the Neck Disability Index (NDI), 81 and the reliability of the PSFS was found to be excellent and that of the NDI to be good. Cleland et al 10 assessed the clinimetrics of the PSFS and the NDI in individuals with cervical radiculopathy and found their reliability to be good and poor, respectively.
Two studies by Nourbakhsh and Fearon 53,54 investigated the use of the PSFS in patients with chronic lateral epicondylitis and found conflicting reliability scores. The first 53 indicated poor reliability, while the second 54 indicated excellent reliability. Good reliability has been shown for use of the PSFS in knee dysfunction.
7
Studies assessing clinimetrics of the PSFS for individuals with knee dysfunction, cervical radiculopathy, or chronic and mechanical low back pain have found the SEM to be between 0.41 and 1.5 PSFS points on a scale of 0 to 10. 7,10,46,70 Westaway and Stratford 81 found the SEM to be 0.43 PSFS points for the average of 3 activities and 0.5 for a single activity.
Validity
Seven of the reviewed articles assessed the validity of the PSFS. Of these, 5 evaluated the concurrent validity in relation to various outcome measures specific to the condition in question, 10, 16, 18, 70, 81 1 assessed predictive validity, 28 and 7 discussed aspects of construct validity. 
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Westaway and Stratford 81 investigated concurrent validity and found correlations between the average PSFS activity score and the NDI score in individuals with neck dysfunction at initial assessment (r = 0.82; lower 95% confidence limit, 0.68) and at discharge (r = 0.83; lower 95% confidence limit, 0.69). Additionally, correlations were established between the prognosis rating and both measures, with the average PSFS scores (r = 0.64; lower 95% confidence limit, 0.40) having a similar strength relationship to that of the NDI scores at discharge (r = 0.66; lower 95% confidence limit, 0.40). 81 Investigating concurrent validity in a population with cervical radiculopathy, Cleland et al 10 showed a correlation between score changes of the PSFS and the numeric pain rating scale (r = 0. 80 
Responsiveness
Ten studies investigated responsiveness of the PSFS (APPENDIX C). The MDC of the PSFS has been found to be between 1.0 and 2.5 PSFS points for individuals with knee dysfunction, neck dysfunction, cervical radiculopathy, chronic low back pain, or chronic obstructive pulmonary disease. 7, 10, 46, 55, 81 In those with neck dysfunction, the MDC was calculated to be 0.99 PSFS points for an average of 3 activities and 1.18 PSFS points for an individual activity. 81 Minimum clinically important difference (MCID) for the PSFS has been investigated in individuals with knee dysfunction, cervical radiculopathy, and chronic low back pain, and was found to be between 2.0 and 3.0 points.
7,10,46
Stratford et al 70 found the average of the MCID scores for 3 activities to be 0.8 ("small change"), 3.2 ("medium change"), and 4.3 ("large change") PSFS points in patients with chronic low back pain.
The PSFS has been found to be more responsive than the RMQ and the FRI when administered in a Brazilian-Portuguese version to individuals with acute low back pain. 16 In that study, an ES of 0.95 (84% CI: 0.84, 1.06) was found and, when correlated with changes in the GPE scale at discharge, produced an r of 0.34 (P<.01). The PSFS also demonstrated a significantly larger AUC (0.72) than both the RMQ and the FRI, when compared to the GPE scale using a cut-off of 2 or more GPE points. No significant ceiling or floor effects were found for the PSFS, as the maximum or minimum score was reported by less than 15% of participants.
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In a study by McMillan and Binhammer, 49 the PSFS was found to be responsive for those with carpal tunnel syndrome (0.65 SRM) and finger contracture (0.64 SRM) preoperatively and 2 months postoperatively. That study also reported that the PSFS was not sufficiently responsive in individuals with wrist pain or tumor, and was less responsive overall than the Michigan Hand Questionnaire.
The PSFS was found to be significantly more responsive than the SF-36 physical summary score in individuals with chronic whiplash. 68 In that study, internal responsiveness indicated an ES of 1.22 (84% CI: 1.06, 1.37) and an SRM of 0.96 (84% CI: 0.84, 1.08), while external responsiveness showed a correlation when comparing the PSFS to the GPE scale, producing an r value of 0.40 and an AUC of 0.71. Cleland et al 10 independently measured the responsiveness of the PSFS in a population with cervical radiculopathy and found an AUC of 0.99 (95% CI: 0.96, 1.0).
Pengel et al 58 compared the responsiveness of 5 outcome measures that assessed pain, disability, and impairment in patients with subacute low back pain and determined that the PSFS was the most responsive, with an ES of 1.6 (84% CI: 1.4, 1.8). These authors found the scale to have a ratio of 2.1 on the Guyatt's responsiveness index, representing large responsiveness. 40 When the PSFS was correlated with the GPE scale, an r of 0.6 (95% CI: 0.5, 0.7) was produced.
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Application as a Clinical Outcome Measure
Fifty-five studies used the PSFS as a clinical outcome measure; these are summarized in APPENDIX D. The PSFS was used as a primary outcome measure in 29 studies and a secondary outcome measure in 22. In 4 studies, use of the PSFS fell into the unclear category, from which only the results relevant to the use of the PSFS are presented in APPENDIX D. In the last column of APPENDIX D are annotated comments that focus on whether the PSFS had been satisfactorily validated in the studied population and if the results reported exceeded the MCID for that population. When the MCID had not been determined in the studied population, the MCID was taken to be 2.3 PSFS points (representative of the MCID values determined in part 1).
The PSFS change scores exceeded the MCID in the results of 39 studies, with 8 studies reporting results that did not surpass MCID. Magnitude of change was unclear or unreported in 14. Forty-seven of the 55 studies used the PSFS in a patient population for which both validity and responsiveness are yet to be established. Twenty-three of the studies used the PSFS in a patient population in which it had not yet been investigated; therefore, reliability, validity, and responsiveness were unknown. Those populations for which PSFS use had not yet been validated included various musculoskeletal-, neurological-, and cardiopulmonary-related conditions. No comment could be made on studies of which the reported results were not clearly described or studies that used the PSFS at baseline only.
DISCUSSION
Psychometrics and Clinimetrics
T he data collated in this review show the PSFS to be psychometrically and clinimetrically sound in a range of body regions and/or musculoskeletal conditions. The findings are summarized in TABLE 4. The PSFS was found to demonstrate sufficient validity, reliability, and responsiveness in populations with knee dysfunction, acute low back pain, mechanical low back pain, cervical radiculopathy, and neck dysfunction. The scale was found to be reliable and responsive in populations with chronic low back pain. The PSFS also demonstrated validity in individuals who had surpassed expected healing times, reliability in individuals with chronic lateral epicondylitis, and responsiveness in individuals presenting with carpal tunnel syndrome, finger contracture, subacute low back pain, and chronic whiplash.
In this review, 2 aspects of clinimetrics (reliability and responsiveness) and varying psychometric properties (forms of validity) were reported. Of the 9 studies reporting reliability results for the PSFS, 5 found excellent results, 3 good results, and 1 poor reliability. It must be noted, however, that the criterion used in this review to define scores classified as good was higher than that used in several of the studies reviewed. 46, 53, 54 According to the criteria used in these studies, the PSFS was generally found to have good, if not excellent, reliability. The scale was found to be more reliable in a study of patients with chronic low back pain 46 compared to one of acute low back pain, 16 indicating that the scale may be more useful in some stages of the clinical course of some conditions.
Validation of an abstract concept, such as function, is difficult to establish. The established accepted current "reference standard" outcome measures for many study populations allow concurrent validity of patient-specific measures to be evaluated. 61 Construct validity is less well defined but appropriate in validating such an abstract concept. The PSFS was compared to the SF-36 in 2 of the studies reviewed, 7,28 which supported the validity of the PSFS for assessing physical function and physical life roles. Both studies found high correlations with role
limitation-physical, physical, and social function (convergent validity), and low correlations with role limitation-emotional, general, and mental health (divergent validity). These findings highlight that self-reported activities enable the interpretation of functional limitation. A low correlation was found with the GPE (r = 0.33), which may be due to its focus on health transition rather than functional status.
The MCID was found to be between 2.0 and 3.0 PSFS points, in a range of conditions and areas affected. Taking into account that the PSFS uses an 11-point (0-10) scale, this MCID range indicates that the PSFS has the capacity to be a responsive and clinically meaningful outcome measure. The PSFS was found to be more responsive in specific, rather than generic, conditions. 68 In the study by McMillan and Binhammer, 49 the PSFS was found to be unresponsive in individuals with wrist pain, which is inconsistent with all other findings in clinimetric studies of the scale to date. This is possibly due to the PSFS being a measure of physical function, rather than one of pain, and perhaps this should be reassessed before disregarding use of the scale in this region.
Use of the PSFS as a Clinical Outcome Measure
The PSFS allows each patient to nominate any activity that he or she may be having difficulty performing due to the patient's health condition. As each activity is self-generated by the patient, the scale is, by definition, patient specific. Because the PSFS takes into account what the patient considers to be the most affected aspects of his or her life at the time of assessment, it can be regarded as a patient-centered measure of outcome. The PSFS has been mapped to the International Classification of Functioning, Disability and Health, a model developed by the World Health Organization that is used globally in physiotherapy practice. 23 The PSFS was designed to detect a change in an individual's perceived functional status for musculoskeletal conditions. The activities nominated invariably differ between individuals, making it difficult to compare the results between patients and to calculate the clinimetrics of the PSFS.
7 Its use as a baseline measure only (rather than an outcome measure to detect change over time) or to make comparisons between groups cannot be supported, as its validity for these uses has not been established. As shown in APPENDIX D, the PSFS has been used in a wide variety of clinical research settings; however, the validity of using the PSFS in many of these designs is questionable.
Similarly, although the PSFS has been found to be clinimetrically sound in a number of musculoskeletal conditions (TABLES 2 and 4), when it is used in populations in which its measurement properties have not yet been established, the results become less meaningful. There does appear to be potential for use of the scale beyond musculoskeletal practice; but the appropriateness of using the PSFS in neurological conditions (along with a number of other musculoskeletal conditions) is yet to be investigated, and in cardiopulmonary conditions only chronic obstructive pulmonary disease has been partially investigated (TABLE 5) .
As a result of increased research and use of the measure, various reputable organizations have recommended the use of the PSFS in practice. The PSFS is recommended in the Dutch Physiotherapy Guidelines for Low Back Pain as 1 of 2 useful tools to assess function in patients with low back pain. 5 The Orthopaedic Section of the American Physical Therapy Association, in its clinical guidelines, suggests the use of self-report outcome measures such as the PSFS in patients with neck pain. 8 Hefford et al 37 performed a pilot study assessing the use of the PSFS in a physiotherapy clinic setting across multiple conditions and concluded that, although further research was required, there was strong potential for the measure to be used in a wide variety of conditions. They found the PSFS to be fast and efficient, with low respondent or administrative burden. 37 Since then, Physiotherapy New Zealand and New Zealand's national no-fault accident and injury insurer, ACC, have both recommended the PSFS as a default outcome measure for all musculoskeletal conditions.
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As well as these recommendations, a number of studies have reported the potential for the inclusion of the PSFS in other areas of practice. Potential benefits were seen for the use of the PSFS in patients attending rehabilitation programs for cardiac or pulmonary disease; though reliability and validity of the PSFS for use in these health conditions would need to be established. 6 Neurological and cardiorespiratory rehabilitation programs may be sufficiently similar in context to musculoskeletal rehabilitation programs to similarly benefit from the use of a patient-centered outcome measure such as the PSFS.
Limitations of the Included Studies
When considering an abstract construct like functional status, assessment becomes a challenge due to the absence of an established gold standard by which to assess clinimetric properties. 40 Assessments of these properties are instrumentand situation-specific, thus making it difficult to apply findings in clinical settings, where a diverse range of conditions are encountered. Also, bias can be introduced by systematic differences in the administration of the measures and measures being named inconsistently from one article to another.
Currently, an extensive number of statistical methods describe the various components of clinimetrics, with an assortment of definitions of their parameters. Subsequently, this makes it difficult to compile the findings from the various studies. The ICC was used to measure reliability in a number of the articles reviewed. There was variability in the parameters used in the studies, which graded the ICC results as excellent, good, or poor. Conflicting reliability results in otherwise similar populations raises the possibility of design flaws or calculation errors. The variety of study designs and range of sample sizes revealed by the review produce other potential sources of uncertainty.
A number of the studies included in the second aim of this review used the PSFS in patient populations for which the reliability, validity, or responsiveness of the PSFS has not been investigated, and, in comparing group-level data, for which the PSFS has not been sufficiently validated. This affects readers' ability to draw meaning from the results of the studies and, therefore, hinders valid translation into the clinical setting.
Limitations of the Review
Despite efforts to minimize them, this systematic review had the following limitations. The search terms used in the electronic database searching ("PatientSpecific Functional Scale" and "Patient Specific Functional Scale") might have limited returned articles, potentially missing articles that used the same measure under a slightly different name. This was considered reasonable, as the review was intended to focus on the PSFS rather than any modified version. However, hand-searched reference lists did provide examples of articles that used slightly different terminology. 50 There was a chance of publication bias, as only published, peer-reviewed articles were included in the review. The breadth and extent of the database search attempted to minimize this bias. Some relevant studies might have been missed due to these criteria; however, lack of peer review might have clouded the accuracy and significance of the results of such studies. It would also have been very difficult to exhaustively include all sources of unpublished data. To minimize language bias we did not impose language limits in the database searches. Although 2 articles in languages other than English were found, both were subsequently excluded via exclusion criteria.
The types of studies included in this review were heterogeneous, particularly in regard to the clinimetrics used, which posed difficulties for summarizing the results. This was deemed to be a necessary limitation, as the aim was to include the widest possible range of published, peerreviewed studies.
Another limitation included quality assessment of the included clinimetric studies. There is no gold standard instrument for assessing the quality of 72 has not been independently assessed and may not accurately reflect methodological quality. The authors found that the tool did not encompass all of the statistics (ES and SRM, for example) used by the various studies in this review. Some sections of the checklist were not relevant to all study types, and those sections that the authors found not to be relevant were disregarded. The effect of this limitation was minimized, as it was used only as an indicator of quality and did not affect the conclusions drawn.
There was no blinding of the authors at any stage of the review; however, this is not universally considered essential in a systematic review. The inclusion criteria were broad so as to allow the maximum number of relevant articles to be included, and selection bias was minimized by having a second investigator confirm the categorization of each article.
CONCLUSION T
he PSFS is valid, reliable, and responsive for measuring change over time in individual patients with a limited range of musculoskeletal conditions, including knee, low back, and neck dysfunction. The majority of psychometric and clinimetric studies reviewed found the PSFS to be reliable, valid, and responsive in a limited range of musculoskeletal populations. Although the use of the PSFS as an outcome measure is increasing in physiotherapy practice, there is a need for more psychometric and clinimetric evidence to support its use. The measurement properties of the PSFS have not yet been established for use in many patient populations, or for use with group-level data. This review found that the PSFS is currently being used in populations beyond those in which there is evidence of its validity and reliability. In particular, psychometric and clinimetric research of the PSFS is required in the areas of neurological and cardiorespira- 70 Clinician to read and fill in. Complete at the end of the history and prior to physical. Test-retest reliability estimated using ICC and SEM Validity assessed using 2 constructs MDC, SEM√2 and associated Conditions/regions studied Cervical radiculopathy Study type
Read at Baseline Assessment
Prospective cohort study Use of the PSFS Primary outcome measure; at baseline and discharge to determine individual improvement and classify treatment as successful or unsuccessful for the individual Reported PSFS results Score change of 2+ points in 50 participants (successful) Score change of less than 2 points in 46 participants (unsuccessful) Mean baseline measurement  SD for all subjects was 4.2  1.3, successful baseline was 4.0  1.2, and unsuccessful baseline was 4.5  1.3 (P = .18) A mean  SD discharge measurement was 7.5  2.0, successful discharge was 8.3  1.1, and unsuccessful discharge was 6.6  2. Mean  SD scores for 3 activities (0-30 PSFS points): PSFS baseline: G1, 10.1  4.2; G2, 10.7  4.0; G3, 11.2  4.6 PSFS at 8 wk: G1, 14.4  6.6; G2, 17.7  6.2; G3, 17.5  6.8 PSFS at 6 mo: G1, 15.0  7.4; G2, 16.4  6.6; G3, 17.3  7.0 PSFS at 12 mo: G1, 13.9  7.2; G2, 15.7  6.8; G3, 15.2  6.8 Between-group difference (G2 and G1) at 8 wk: 2.9 (0.9, 4.8) (P = .04) Between-group difference (G3 and G1) at 8 wk: 2.3 (0.4, 4.2) (P = .016) Between-group difference (G2 and G3) at 8 wk: 0.4 (-1.5, 2.4) (P = . The PSFS score change in 13 participants for 2 ADL activities: (1) 0, 0; (2) 1, 1; (3) excluded during trial; (4) 1, 1; (5) NA; (6) 2 (only named 1 ADL); (7) 0, -1; (8) NA; (9) 0 (only named 1 ADL); (10) excluded during trial; (11) 3, 4; (12) 1, 5; (13) The effect of advice on the PSFS score was 0.7 points (95% CI: 0.1, 1.3) at 6 wk and 0.6 points (95% CI: 0.1, 1.2) at 12 mo The effect of exercise was 0.4 points (95% CI: -0.2, 1.0) at 6 wk and 0.5 points (95% CI: -0.1, 1.0) at 12 mo The effect of exercise and advice combined was 1.1 points (95% CI: 0.3, 1.9) at 6 wk and 1.1 points (95% CI: 0. The median (min-max) PSFS scores for group 1: baseline, 3.0 (2.0-6.4); 2 wk, 4.2 (2.0-9.0); 1 mo, 5.3 (2.0-9.0); 3 mo, 4.6 (2.0-9.0) The median (min-max) PSFS scores for group 2: baseline, 2.3 (1.8-5. Preliminary RCT Use of the PSFS Primary outcome measure; at baseline, 6, 12, 18, and 24 wk to compare between 3 groups (G1, G2, G3) Reported PSFS results 1 group had significantly better PSFS scores after intervention (P = .001) than the other 2 groups G1 PSFS  SD scores: baseline, 3.6  0.7; 6th wk, 7.7  0.8; 12th wk, 7.8  0.9; 18th wk, 8.0  0.9; 24th wk, 8.5  0.9 G2 PSFS  SD scores: baseline, 5.5  0.7; 6th wk, 6.2  0.9; 12th wk, 5.6  1.0; 18th wk, 5.0  1.0; 24th wk, 5.6  1.0 G3 PSFS  SD scores: baseline, 6.5  0.7; 6th wk, 6.7  0.9; 12th wk, 5.4  1.0; 18th wk, 6.8  aPPEnDix D
